Consolidated Statement of Cash Flows - USD ($) $ in Thousands	9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021
OPERATING ACTIVITIES
Net income	$ 4,902	$ (499)
Adjustments to reconcile net income to net cash (used for) provided by operating activities:
Provision for loan losses	1,190	548
Depreciation	607	376
Amortization of intangible assets	197	320
(Accretion) amortization of premiums and (discounts), net	(903)	1,170
Origination of loans to be sold	(9,362)	(12,079)
Proceeds from loan sales	10,115	13,192
Gain on sale of loans	(753)	(316)
Share-based and deferred compensation	493
Bank-owned life insurance income	(381)	(176)
Gain on sale of debt securities, available for sale	(13)
Change in accrued interest receivable and other assets	(1,397)	457
Change in accrued interest payable and other liabilities	56	2,424
Net cash provided by operating activities	4,751	5,417
Investment securities available for sale:
Proceeds from sales	513
Proceeds from calls and maturities	1,150	1,380
Proceeds from principal repayments	9,748	16,332
Purchases		(14,192)
Investment securities held to maturity
Proceeds from principal repayments	1,826
Purchases	(34,389)
Purchase of certificates of deposit with other banks		(249)
Proceeds from redemptions of certificates of deposit with other banks	4,470	4,223
Purchase of restricted investment in bank stocks	(4,525)	(500)
Redemption of restricted investment in bank stocks	3,883	221
Increase in loans, net	(143,654)	(16,708)
Proceeds from death benefit under bank-owned life insurance	41	218
Purchase of premises and equipment	(4,405)	(111)
Net cash acquired through merger and acquisition		39,885
Net cash (used in) provided by investing activities	(165,342)	30,499
FINANCING ACTIVITIES
Increase in deposits, net	180,045	36,311
Change in short-term borrowings, net	(19,814)
Proceeds from issuance of subordinated debt	20,000
Repayments of other borrowings		(1,120)
Issuance of shares from exercise of stock options	120
Dividends paid	(2,213)	(725)
Net proceeds from issuance of common stock	34,659
Net cash provided by financing activities	212,797	34,466
Increase in cash and cash equivalents	52,206	70,382
CASH AND CASH EQUIVALENTS AT BEGINNING OF PERIOD	22,590	33,162
CASH AND CASH EQUIVALENTS AT END OF PERIOD	74,796	103,544
SUPPLEMENTAL CASH FLOW DISCLOSURES
Interest	3,243	1,614
Income taxes	$ 275	560
Non-cash assets acquired:
Securities available for sale		3,111
Loans		415,905
Investments in restricted bank stock		1,039
Premises and equipment		2,087
Right-of-Use Asset		4,384
Bank-owned life insurance		4,784
Goodwill		33,179
Intangible assets		1,246
Deferred tax assets		3,591
Accrued interest receivable and other assets		3,868
Liabilities assumed:
Deposits		391,160
Other borrowings		33,034
Subordinated debt		20,740
Operating lease liabilities		4,384
Accrued interest payable and other liabilities		2,026
Net non-cash assets acquired		61,396
Cash and cash equivalents acquired		$ 49,962